Observational retrospective study about effectiveness and safety of insulin Faster Aspart on continuous subcutaneous insulin infusion treated adult Type 1 Diabetes Mellitus (T1DM) patients in routine clinical practice.
Cross-sectional retrospective analysis about effectiveness and safety of insulin Faster Aspart on continuous subcutaneous insulin infusion treated adult Type 1 Diabetes Mellitus (T1DM) patients in routine clinical practice. All clinical variables are gathered from two EMR softwares (Mambrino XXI and Carelink Pro®). Data analysis is conducted using SPSS (Chicago, IL) statistics software. Results are presented as mean ± SD values or percentages. A paired Student's t-test or a Wilcoxon signed-rank test were used for the analysis of differences. Comparisons between proportions were analyzed using a chi-squared test. A P value \< 0.05 was considered statistically significant. The protocol was approved by the reference Castilla-La Mancha Public Health Institute Ethic Committee. All participants provided written informed consent.
Study Type
OBSERVATIONAL
Enrollment
48
Currently receiving Faster Aspart during 3 or more months.
Currently receiving CSII therapy during 6 or more months.
Obispo Rafael Torija, St.
Ciudad Real, Spain
MAGE
Differences from basal to 3 months after Faster Aspart initiation on Mean Amplitude of Glucose Excursions (MAGE).
Time frame: 3 months
VCo
Differences from basal to 3 months after Faster Aspart initiation Variation Coefficient (VCo).
Time frame: 3 months
M100
Differences from basal to 3 months after Faster Aspart initiation on M100.
Time frame: 3 months
GRADE
Differences from basal to 3 months after Faster Aspart initiation on Glycemia Risk Assessment Diabetes Equation (GRADE).
Time frame: 3 months
J-index
Differences from basal to 3 months after Faster Aspart initiation on J-index.
Time frame: 3 months
MODD
Differences from basal to 3 months after Faster Aspart initiation on MODD.
Time frame: 3 months
CONGA
Differences from basal to 3 months after Faster Aspart initiation on CONGA.
Time frame: 3 months
HbA1c
Differences from basal to 3 months after Faster Aspart initiation on Hemoglobin A1C (HbA1C).
Time frame: 3 months
Hypoglycemic frequency
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Differences from basal to 3 months after Faster Aspart initiation on hypoglycemic frequency.
Time frame: 3 months
TIR-TAR-TUR
9\. Differences from basal to 3 months after Faster Aspart initiation on time in range, time above range and time under range.
Time frame: 3 months